• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIANG Feng, LI Duo, WANG Rongbin, SHU Chang, DING Li. Pharmacokinetics and absolute bioavailability of isoschaftoside in rat by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2019, 50(1): 75-80. DOI: 10.11665/j.issn.1000-5048.20190110
Citation: LIANG Feng, LI Duo, WANG Rongbin, SHU Chang, DING Li. Pharmacokinetics and absolute bioavailability of isoschaftoside in rat by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2019, 50(1): 75-80. DOI: 10.11665/j.issn.1000-5048.20190110

Pharmacokinetics and absolute bioavailability of isoschaftoside in rat by LC-MS/MS

More Information
  • The aim of this study was to develop a highly sensitive and specific LC-MS/MS method to explore the pharmacokinetic properties and absolute bioavailability of isoschaftoside in rats. Blood sampling was performed at different time points after intragastric administration of isoschaftoside(1. 5, 3. 0, 6. 0 mg/kg)and 0. 5 mg/kg by intravenous injection. Isoschaftoside was analyzed by a validated LC-MS/MS method in plasma; the pharmacokinetic parameters and absolute bioavailability were evaluated by software DAS 3. 0. The results showed that the linear concentration ranges of isoschaftoside was 1. 0- 500. 0 ng/mL(r=0. 997 6). The precision, accuracy, matrix effect, sensitivity, dilution reliability and stability met the requirements of biological sample analysis. For ig administration of isoschaftoside(1. 5, 3. 0, 6. 0 mg/kg), the pharmacokinetic parameter cmax was(109. 34±22. 87), (259. 84±95. 35)and(499. 26±288. 09)ng/mL; AUC0-t was(310. 57±46. 18), (552. 67±207. 14)and(1 075. 03±371. 19)h ·ng/mL; t1/2 was(2. 36±0. 22), (2. 91±0. 19)and(3. 04±0. 86)h; tmax was(1. 03±0. 25), (1. 18±0. 17)and(1. 5±0. 43)h; MRT0-t was(11. 33±1. 53), (11. 27±1. 09)and(8. 29±0. 76)h, respectively. For iv administration of isoschaftoside(0. 5 mg/kg), the pharmacokinetic parameter AUC0-t was(1 536±421. 3)h ·ng/mL; t1/2 was(2. 57±0. 46)h; MRT0-t was(9. 55±2. 37)h. Furthermore, the absolute bioavailability was 6. 73%, 5. 99%, 5. 80%, respectively. The LC-MS/MS analysis method established in this study was accurate and sensitive, so it can be applied to the pharmacokinetic study of isoschaftoside.
  • [1]
    Zhang LL,Xu W,Xu YL,et al.Therapeutic potential of Rhizoma Alismatis:a review on ethnomedicinal application,phytochemistry,pharmacology,and toxicology[J].Ann NY Acad Sci,2017,1401(1):90-101.
    [2]
    Gao X, Sun C, Yu Z, et al. Correlation analysis between the chemical contents and bioactivity for the quality control of Alismatis Rhizoma[J].Acta Pharm Sin B,2018,8(2):242-251.
    [3]
    Chu Y,Jiang H,Ju J,et al.A metabolomic study using HPLC-TOF/MS coupled with ingenuity pathway analysis:intervention effects of Rhizoma Alismatis on spontaneous hypertensive rats[J].J Pharm Biomed Anal,2016,117:446-452
    [4]
    Shan DS,Ming ZH,Chun Qi B,et al.Nematocidal flavone-C-glycosides against the root-knot nematode(Meloidogyne incognita)from Arisaema erubescens tubers[J].Molecules,2011,16(6):5079-5086.
    [5]
    Dai Y,Tan A,Chen H,et al.Quantification of desoxyrhapontigenin(4-methoxyresveratrol)in rat plasma by LC-MS/MS:application to pre-clinical pharmacokinetic study[J].J Pharm Biomed Anal,2018,153:95-101.
    [6]
    Yang M,Dong Z,Jiang X,et al.Determination of S-allylmercaptocysteine in rat plasma by LC-MS/MS and its application to a pharmacokinetics study[J].J Chromatogr Sci,2018.doi: 10.1093/chromsci/bmy001.
    [7]
    Chen JT, Guo XM, Yang P, et al. Quantitative analysis of the cyclic peptide GG-8-6 in rat plasma using LC-MS/MS and its application to a pharmacokinetic study[J].J Pharm Biomed Anal,2018,159:217-223.
    [8]
    Cai J,Zhu L,Xu Y,et al.A UPLC-MS/MS method for determination of schaftoside in rat plasma and its application to phamacokinetic study[J].Lat Am J Pharm,2016,35(3):545-550.
  • Related Articles

    [1]LIU Li, PEI Siran, WU Huali, ZHAO Qingshun, PENG Jixian, SHANG Jing. Drug screening model of treating pigmentation disorders in tyrp1a transgenic zebrafish[J]. Journal of China Pharmaceutical University, 2016, 47(6): 740-743. DOI: 10.11665/j.issn.1000-5048.20160618
    [2]SHAO Xin, YI Qianying, YANG Chunlei. Discovery of novel EphB4 inhibitors based on pharmacophore modeling and virtual screening techniques[J]. Journal of China Pharmaceutical University, 2016, 47(1): 38-47. DOI: 10.11665/j.issn.1000-5048.20160105
    [3]HE Hua, ZHANG Xue, WANG Yuhao, LIU Xiaoquan. Advances in pharmacokinetic and pharmacodynamic modeling of monoclonal antibody[J]. Journal of China Pharmaceutical University, 2015, 46(3): 279-288. DOI: 10.11665/j.issn.1000-5048.20150304
    [4]TANG Chunlei, HUANG Wenlong, QIAN Hai. Construction and application of 3D-pharmacophore model of glucokinase agonists[J]. Journal of China Pharmaceutical University, 2015, 46(2): 181-187. DOI: 10.11665/j.issn.1000-5048.20150208
    [5]HE Xiaobei, LIU Xiaodong. Physiologically based pharmacokinetic model of mechanism-based inhibition of theophylline/caffeine by enoxacin/ciprofloxacin[J]. Journal of China Pharmaceutical University, 2013, 44(1): 77-84. DOI: 10.11665/j.issn.1000-5048.20130113
    [6]REN Xin-yi, CHEN Yuan-cheng, WANG Yan, XIAO Yuan-yuan, LIU Xiao-quan. Pharmacokinetic-pharmacodynamic(PK-PD) modeling of salvianolic acid A on the plasma homocysteine in rats[J]. Journal of China Pharmaceutical University, 2012, 43(3): 260-265.
    [7]Linear Model for Prediction of Drug Shelf Life[J]. Journal of China Pharmaceutical University, 1999, (2): 69-72.
    [8]Yang Jinghua, Song Xiangzheng. The Markovian Model C in Pharmacokinetics[J]. Journal of China Pharmaceutical University, 1997, (1): 59-62.
    [9]Animal ECG Automatic Sample and Analysis-process by Computer[J]. Journal of China Pharmaceutical University, 1995, (5): 304-307.
    [10]Computer Program for the Effect Parameters of Combined Pharmacokinetic and Pharmacodynamic Model[J]. Journal of China Pharmaceutical University, 1990, (3): 142-146.

Catalog

    Article views (1148) PDF downloads (864) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return